State Street Corp Curis Inc Transaction History

State Street Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $963,616 - $3.3 Million	-1,357,207 Reduced 84.18%	255,009 $251,000
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $14.3 Million - $31.7 Million	-6,187,112 Reduced 79.33%	1,612,216 $3.84 Million
Q4 2021 Feb 14, 2022	SELL	$4.45 - $8.09 $179,375 - $326,099	-40,309 Reduced 0.51%	7,799,328 $37.1 Million
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $4.53 Million - $5.78 Million	652,938 Added 9.09%	7,839,637 $61.4 Million
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $19.7 Million - $43 Million	2,639,875 Added 58.06%	7,186,699 $58 Million
Q1 2021 May 17, 2021	BUY	$8.78 - $12.8 $39.6 Million - $57.7 Million	4,508,936 Added 11900.7%	4,546,824 $51.5 Million
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $27,648 - $209,919	25,600 Added 208.33%	37,888 $310,000
Q1 2020 May 11, 2020	BUY	$0.67 - $1.85 $8,232 - $22,732	12,288 New	12,288 $9,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.